| FDMT |
4D Molecular Therapeutics, Inc. |
09 Dec 2025 |
0 |
$0 |
3 |
Chief Commercial Officer |
19 Dec 2025, 16:12 |
| /report/000110465923080685-simms-christopher-paul-2023-07-11 |
IVERIC bio, Inc. |
11 Jul 2023 |
7 |
$0 |
4 |
SVP, Chief Commercial Officer |
13 Jul 2023, 13:58 |
| /report/000141093923000006-simms-christopher-paul-2023-01-02 |
IVERIC bio, Inc. |
02 Jan 2023 |
3 |
-$47,502 |
4 |
SVP, Chief Commercial Officer |
04 Jan 2023, 17:33 |
| /report/000141093922000146-simms-christopher-paul-2022-12-20 |
IVERIC bio, Inc. |
20 Dec 2022 |
2 |
$0 |
4 |
SVP, Chief Commercial Officer |
22 Dec 2022, 17:54 |
| /report/000141093922000092-simms-christopher-paul-2022-08-02 |
IVERIC bio, Inc. |
02 Aug 2022 |
6 |
-$138,060 |
4 |
SVP, Chief Commercial Officer |
04 Aug 2022, 16:09 |
| /report/000110465921151726-simms-christopher-paul-2021-12-16 |
IVERIC bio, Inc. |
16 Dec 2021 |
2 |
$0 |
4 |
SVP, Chief Commercial Officer |
20 Dec 2021, 15:34 |
| /report/000110465921142468-simms-christopher-paul-2021-11-18 |
IVERIC bio, Inc. |
18 Nov 2021 |
1 |
+$50,025 |
4 |
SVP, Chief Commercial Officer |
22 Nov 2021, 15:02 |
| /report/000110465921100270-simms-christopher-paul-2021-08-02 |
IVERIC bio, Inc. |
02 Aug 2021 |
3 |
$0 |
4 |
Senior Vice President, CCO |
04 Aug 2021, 19:53 |
| /report/000110465921100265-simms-christopher-paul-2021-08-02 |
IVERIC bio, Inc. |
02 Aug 2021 |
0 |
$0 |
3 |
Senior Vice President, CCO |
04 Aug 2021, 19:50 |